Harpal Kumar

Last updated
Sir Harpal Kumar
Harpal Kumar Z6Q6532 RT(1).jpg
Kumar in 2014
Born
Harpal Singh Kumar

1965 (age 58–59)
Nationality British
Alma mater St John's College, Cambridge
Harvard Business School

Sir Harpal Singh Kumar (born 1965) is a British medical researcher of Indian descent who had served as the chief executive officer of Cancer Research UK [1] [2] [3] from April 2008 until June 2018, [4] when he became Senior Vice President and Head of Innovation EMEA at Johnson & Johnson. He left the company in April 2020 and now serves as President of GRAIL Europe. [5] [6]

Contents

Early life and education

Kumar's parents were refugees. As Sikhs, they chose to leave what was to become Pakistan and move to India during the Partition of India in 1947, where they ended up in refugee camps. Later they moved to England from India, where his father was employed sweeping factory floors, before eventually starting his own grocery store. [7] [8]

Kumar attended Latymer Upper School in Hammersmith before taking up a place to study Chemical Engineering at the University of Cambridge. He graduated with Master of Engineering and Master of Arts degrees and was awarded the Mobil Prize, Metal Box Prize, and Hughes Prize during his time at Cambridge. He subsequently gained a Master of Business Administration degree with High Distinction as a Baker Scholar at Harvard Business School where he won the Ford Prize and the Wolfe Prize. [9] [10]

Career

After graduation, Kumar was employed by McKinsey and Co. as a healthcare consultant. In 1992 he was appointed chief executive of the disability charity the Papworth Trust. [11] In 1997 he founded Nexan Group, a venture capital-backed medical devices company. [11] He joined Cancer Research Technology Limited as chief executive in 2002 and became chief operating officer of Cancer Research UK in 2004. He became chief executive officer in April 2007 [10] and led the charity for more than a decade before departing for Johnson & Johnson Innovation.

Among his other roles, Kumar is a trustee of the Francis Crick Institute and the Institute for Cancer Research, and chairman of the Board of the National Cancer Research Institute. He is also chairman of the Cancer Outcomes Strategy Advisory Group in England and co-chair of the National Awareness and Early Diagnosis Initiative, [10] the senior Senior Independent Director of Innovate UK and a board member of UK Research and Innovation. [12]

On 10 April 2020 GRAIL Inc. announced Kumar's appointment as President of GRAIL Europe. [13]

Awards and honours

Kumar was knighted in the 2016 New Year Honours for services to cancer research. [14] [15]

Personal life

Kumar is a British-Indian, a British-Punjabi and a British-Sikh.

Kumar lists his recreations as theatre, opera and football. [9]

Related Research Articles

<span class="mw-page-title-main">Cancer Research UK</span> Cancer research and awareness charity

Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

<span class="mw-page-title-main">Peter Gregson (engineer)</span> British research engineer and academic (1957–2024)

Sir Peter John Gregson, FREng was a British research engineer and Chair of the Henry Royce Institute. He was previously the Vice-Chancellor of Cranfield University from 2013-2021 and President and Vice-Chancellor of Queen's University Belfast from 2004. Prior to that he was deputy Vice-Chancellor at the University of Southampton from 2000-2004.

<span class="mw-page-title-main">Young Lives vs Cancer</span>

Young Lives vs Cancer, the operating name for "CLIC Sargent", is a charity in the United Kingdom formed in 2005. Young Lives vs Cancer is the 12th largest cancer charity in the UK with a focus on children, young people and their families. Its care teams provide specialist support across the UK.

<span class="mw-page-title-main">British Heart Foundation</span> United Kingdom charity

The British Heart Foundation (BHF) is a cardiovascular research charity in the United Kingdom. It funds medical research related to heart and circulatory diseases and their risk factors, and runs influencing work aimed at shaping public policy and raising awareness.

<span class="mw-page-title-main">Paul Nurse</span> English geneticist and Nobel laureate

Sir Paul Maxime Nurse is an English geneticist, former President of the Royal Society and Chief Executive and Director of the Francis Crick Institute. He was awarded the 2001 Nobel Prize in Physiology or Medicine, along with Leland Hartwell and Tim Hunt, for their discoveries of protein molecules that control the division of cells in the cell cycle.

<span class="mw-page-title-main">Blood Cancer UK</span>

Blood Cancer UK, is a UK-based charity dedicated to funding research into all blood cancers including leukaemia, lymphoma and myeloma, as well as offering information and support to blood cancer patients.

Sir David Philip Lane is a British immunologist, molecular biologist and cancer researcher. He is currently working in the Department of Microbiology, Tumor and Cell Biology at the Karolinska Institute and is Chairman of Chugai Pharmabody. He is best known for the discovery of p53, one of the most important tumour suppressor genes.

<span class="mw-page-title-main">Leszek Borysiewicz</span> British immunologist

Sir Leszek Krzysztof Borysiewicz is a British professor, immunologist and scientific administrator. He served as the 345th Vice-Chancellor of the University of Cambridge, his term of office started on 1 October 2010 and ended on 1 October 2017. Borysiewicz also served as chief executive of the Medical Research Council of the UK from 2007-2010 and was the chairman of Cancer Research UK from 2016 to 2023.

<span class="mw-page-title-main">Jewish Leadership Council</span>

The Jewish Leadership Council is an organisation in the United Kingdom, founded in 2003, whose declared aim is to forward the interests of the organised Jewish community in Britain. The council was founded by its first chairman, then president of the Board of Deputies of British Jews, Henry Grunwald, and a number of other senior UK Jewish leaders. The council acts as an umbrella group for various Jewish community organizations, charities, Zionist and pro-Israel advocacy groups.

Sir John Oliver Frank Kingman KCB FRS has been Chair of Legal & General PLC since 2016. He is also Chair of Barclays UK, the ring-fenced retail bank of Barclays PLC, and a member of the Barclays PLC board. He was previously Chair of Tesco Bank.

<span class="mw-page-title-main">Jo Johnson</span> British politician (born 1971)

Joseph Edmund Johnson, Baron Johnson of Marylebone, is a British politician and peer who was Minister of State for Universities, Science, Research and Innovation from 2015 to 2018, and from July to September 2019. A member of the Conservative Party, he was Member of Parliament (MP) for Orpington from 2010 to 2019. He currently sits in the House of Lords. His older brother, Boris Johnson, was Prime Minister of the United Kingdom between 2019 and 2022.

<span class="mw-page-title-main">Francis Crick Institute</span> Biomedical research centre in London

The Francis Crick Institute is a biomedical research centre in London, which was established in 2010 and opened in 2016. The institute is a partnership between Cancer Research UK, Imperial College London, King's College London (KCL), the Medical Research Council, University College London (UCL) and the Wellcome Trust. The institute has 1,500 staff, including 1,250 scientists, and an annual budget of over £100 million, making it the biggest single biomedical laboratory in Europe.

Sir Tony Kouzarides, FMedSci, FRS is a senior group leader Gurdon Institute, a founding non-executive director of Abcam and a Professor of Cancer Biology at the University of Cambridge.

<span class="mw-page-title-main">The Christie</span> Hospital in Manchester, England

The Christie, formerly known as Christie Hospital, is a specialist National Health Service oncology hospital in Manchester, England. It is one of the largest cancer treatment centres in Europe. It is managed by The Christie NHS Foundation Trust, which as of 2024 had a turnover of £472 million and around 3,500 staff, and its work is also supported by The Christie Charity.

<span class="mw-page-title-main">Breast Cancer Now</span> Charity in the UK

Breast Cancer Now is a charity in the United Kingdom which was formed in 2015 by the merger of Breast Cancer Campaign and Breakthrough Breast Cancer. It is the United Kingdom's largest breast cancer charity. Its declared "Action Plan" is "by 2050, everyone who develops breast cancer will live".

Peter Goodhand is a senior executive and board member in the health research advancement community.

UK Research and Innovation (UKRI) is a non-departmental public body of the Government of the United Kingdom that directs research and innovation funding, funded through the science budget of the Department for Science, Innovation and Technology.

<span class="mw-page-title-main">Gina Long</span> Philanthropist, entrepreneur, journalist, radio presenter and global charity campaigner

Gina Long is a philanthropist, entrepreneur, journalist, radio presenter and global charity campaigner. She was awarded an MBE for services to the charity sector in December 2015. She was made a Honorary Fellow of the University of Suffolk in October 2018.

<span class="mw-page-title-main">Michelle Mitchell</span>

Michelle Elizabeth Mitchell is the Chief Executive of Cancer Research UK. She has worked extensively in the charity sector, having led Age UK, the Multiple Sclerosis Society of Great Britain and the Fawcett Society.

References

  1. ↑ Caroline Crampton interviews Harpal Kumar about cigarette marketing. Archived 2016-03-04 at the Wayback Machine Total Politics.
  2. ↑ Five minutes with Dr Harpal Kumar of Cancer Research UK. theguardian.
  3. ↑ NCRI Cancer Conference (21 May 2013). "Dr Harpal Kumar talks about the work of the NCRI partnership". Archived from the original on 2021-12-14 – via YouTube.
  4. ↑ "Sir Harpal Kumar to leave Cancer Research UK next year | UK Fundraising". UK Fundraising. 2017-10-02. Retrieved 2018-11-09.
  5. ↑ "GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe". GRAIL. Retrieved 19 May 2024.
  6. ↑ "Sir Harpal Kumar". JNJ Innovation. 2018-09-10. Archived from the original on 2018-11-09. Retrieved 2018-11-09.
  7. ↑ Werdigier, Julia (6 January 2013). "Judging What's Important". New York Times. Retrieved 12 January 2015.
  8. ↑ "Sir Harpal Kumar: 'Charities could be more ambitious", Tania Mason,interview, Civil Society, 4 Jun 2019
  9. 1 2 "Harpal Singh KUMAR" Debrett's People of Today. Retrieved 11 January 2015.
  10. 1 2 3 Chief Executive and Executive Board. Cancer Research UK. Retrieved 11 January 2015.
  11. 1 2 "Charity events - trustee training - Harpal Kumar". Archived from the original on 2016-10-12. Retrieved 2016-09-07.
  12. ↑ "Sir Harpal Kumar - UK Research and Innovation". www.ukri.org. Archived from the original on 2018-11-09. Retrieved 2018-11-09.
  13. ↑ "GRAIL Appoints Sir Harpal Kumar as President of GRAIL Europe". grail.com. Retrieved 2020-04-10.
  14. ↑ "No. 61450". The London Gazette (Supplement). 30 December 2015. p. N2.
  15. ↑ "New Year's Honours 2016 list" (pdf). GOV.UK. 30 December 2015. Retrieved 30 December 2015.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.